^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    DCTY0801

    i
    Other names: DCTY0801, EGFRvIII CAR-T, DCTY-0801, DCTY 0801
    Associations
    News
    Trials
    Company:
    Beijing DCTY Biotech
    Drug class:
    EGFRvIII-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials